chr17-48597836-C-G

Variant summary

Our verdict is Benign. The variant received -8 ACMG points: 0P and 8B. BP4_StrongBS2

The NM_018952.5(HOXB6):​c.315G>C​(p.Lys105Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000135 in 1,602,318 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.00046 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00010 ( 0 hom. )

Consequence

HOXB6
NM_018952.5 missense

Scores

2
8
9

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 0.954
Variant links:
Genes affected
HOXB6 (HGNC:5117): (homeobox B6) This gene is a member of the Antp homeobox family and encodes a protein with a homeobox DNA-binding domain. It is included in a cluster of homeobox B genes located on chromosome 17. The encoded protein functions as a sequence-specific transcription factor that is involved in development, including that of lung and skin, and has been localized to both the nucleus and cytoplasm. Altered expression of this gene or a change in the subcellular localization of its protein is associated with some cases of acute myeloid leukemia and colorectal cancer. [provided by RefSeq, Jul 2008]
HOXB-AS3 (HGNC:40283): (HOXB cluster antisense RNA 3)
HOXB3 (HGNC:5114): (homeobox B3) This gene is a member of the Antp homeobox family and encodes a nuclear protein with a homeobox DNA-binding domain. It is included in a cluster of homeobox B genes located on chromosome 17. The encoded protein functions as a sequence-specific transcription factor that is involved in development. Increased expression of this gene is associated with a distinct biologic subset of acute myeloid leukemia (AML). [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -8 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.028879791).
BS2
High AC in GnomAd4 at 70 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
HOXB6NM_018952.5 linkc.315G>C p.Lys105Asn missense_variant Exon 3 of 4 ENST00000225648.4 NP_061825.2 P17509-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
HOXB6ENST00000225648.4 linkc.315G>C p.Lys105Asn missense_variant Exon 3 of 4 1 NM_018952.5 ENSP00000225648.3 P17509-1

Frequencies

GnomAD3 genomes
AF:
0.000460
AC:
70
AN:
152252
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00135
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000458
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.0000735
Gnomad OTH
AF:
0.000478
GnomAD2 exomes
AF:
0.000215
AC:
49
AN:
227746
AF XY:
0.000185
show subpopulations
Gnomad AFR exome
AF:
0.00167
Gnomad AMR exome
AF:
0.000272
Gnomad ASJ exome
AF:
0.000419
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000120
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000101
AC:
146
AN:
1449948
Hom.:
0
Cov.:
31
AF XY:
0.0000986
AC XY:
71
AN XY:
720012
show subpopulations
African (AFR)
AF:
0.00118
AC:
39
AN:
33134
American (AMR)
AF:
0.000229
AC:
10
AN:
43754
Ashkenazi Jewish (ASJ)
AF:
0.000425
AC:
11
AN:
25902
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39082
South Asian (SAS)
AF:
0.0000118
AC:
1
AN:
84632
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
52250
Middle Eastern (MID)
AF:
0.00139
AC:
8
AN:
5750
European-Non Finnish (NFE)
AF:
0.0000497
AC:
55
AN:
1105676
Other (OTH)
AF:
0.000368
AC:
22
AN:
59768
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.483
Heterozygous variant carriers
0
8
17
25
34
42
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000459
AC:
70
AN:
152370
Hom.:
0
Cov.:
32
AF XY:
0.000362
AC XY:
27
AN XY:
74514
show subpopulations
African (AFR)
AF:
0.00135
AC:
56
AN:
41600
American (AMR)
AF:
0.000457
AC:
7
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5182
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4832
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10632
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.0000735
AC:
5
AN:
68024
Other (OTH)
AF:
0.000473
AC:
1
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
3
7
10
14
17
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000127
Hom.:
0
Bravo
AF:
0.000476
ESP6500AA
AF:
0.00136
AC:
6
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.000231
AC:
28
Asia WGS
AF:
0.000289
AC:
1
AN:
3478

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Feb 16, 2023
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.315G>C (p.K105N) alteration is located in exon 3 (coding exon 1) of the HOXB6 gene. This alteration results from a G to C substitution at nucleotide position 315, causing the lysine (K) at amino acid position 105 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.63
BayesDel_addAF
Benign
-0.22
T
BayesDel_noAF
Benign
-0.12
CADD
Pathogenic
27
DANN
Uncertain
1.0
DEOGEN2
Benign
0.39
T;T
Eigen
Uncertain
0.58
Eigen_PC
Uncertain
0.57
FATHMM_MKL
Uncertain
0.96
D
LIST_S2
Benign
0.75
.;T
M_CAP
Benign
0.065
D
MetaRNN
Benign
0.029
T;T
MetaSVM
Uncertain
0.34
D
MutationAssessor
Uncertain
2.3
M;M
PhyloP100
0.95
PrimateAI
Pathogenic
0.83
D
PROVEAN
Benign
-1.9
N;N
REVEL
Uncertain
0.36
Sift
Uncertain
0.022
D;D
Sift4G
Benign
0.070
T;T
Polyphen
0.99
D;D
Vest4
0.55
MutPred
0.30
Loss of ubiquitination at K105 (P = 0.0014);Loss of ubiquitination at K105 (P = 0.0014);
MVP
0.95
MPC
0.40
ClinPred
0.038
T
GERP RS
5.4
Varity_R
0.23
gMVP
0.55
Mutation Taster
=59/41
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs143197683; hg19: chr17-46675198; API